EPO Patents = 2

Forward Citations = 2

Loading Chart...

8 inventors (with patents filed for the assignee):

Xiaohu Deng (3 out of 22 patents)

Wanping Mai (2 out of 3 patents)

Biljana Nadjsombati (2 out of 2 patents)

4. Robert C Mcrae (2 out of 2 patents)

5. Douglas V Faller (1 out of 19 patents)

6. Ronald Jay Berenson (1 out of 26 patents)

7. Stewart Jones (1 out of 1 patent)

8. David Slack (1 out of 1 patent)

9. James N Woody (1 out of 2 patents)

10. Patrick Soon-Shiong (477 patents)

5 patents: Sort by Forward Citations

1. 12740986 - Histone deacetylase inhibitors for use in immunotherapy (2026-09-22),

2. 12083119 - Methods and compositions for treating viral or virally-induced conditions (2024-09-10),

3. 12012396 - HDAC inhibitor solid state forms (2024-06-18),

4. 11780822 - HDAC inhibitor solid state forms (2023-10-10),

5. 11760748 - HDAC inhibitor solid state forms (2023-09-19),

Company Overview

Viracta Subsidiary, Inc. is a biotechnology company focused on developing targeted therapeutics for the treatment of virus-associated cancers. With a proprietary technology platform, the company is advancing novel therapies to address unmet medical needs in oncology. Viracta is dedicated to improving outcomes for patients by harnessing the power of precision medicine.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

5 Patents

#4 in Cardiff, CA

#12,073 in California

#51,644 in US

Cardiff, CA, United States of America

Viracta Subsidiary, Inc.

Forward Citations = 2

8 inventors:

Xiaohu Deng (3 out of 22 patents)

Wanping Mai (2 out of 3 patents)

Biljana Nadjsombati (2 out of 2 patents)

4. Robert C Mcrae (2 out of 2 patents)

5. Douglas V Faller (1 out of 19 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Viracta Subsidiary, Inc.. Retrieved from https://idiyas.com/company/viracta-subsidiary

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]